NASDAQ:SYBX - Synlogic Stock Price, Forecast & News

Synlogic's stock was trading at $1.54 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SYBX stock has increased by 19.5% and is now trading at $1.84. View which stocks have been mosted impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Synlogic in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Synlogic.

Synlogic is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Synlogic.

Synlogic Inc (NASDAQ:SYBX) issued its quarterly earnings results on Thursday, March, 12th. The biotechnology company reported ($0.37) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.44) by $0.07. The biotechnology company had revenue of $1.23 million for the quarter, compared to analysts' expectations of $0.63 million. Synlogic had a negative return on equity of 33.22% and a negative net margin of 2,310.98%. View Synlogic's earnings history.

Synlogic's stock reverse split on Monday, August 28th 2017. The 1-7 reverse split was announced on Friday, August 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 25th 2017. An investor that had 100 shares of Synlogic stock prior to the reverse split would have 14 shares after the split.

7 Wall Street analysts have issued twelve-month price objectives for Synlogic's shares. Their forecasts range from $2.00 to $25.00. On average, they anticipate Synlogic's stock price to reach $14.17 in the next year. This suggests a possible upside of 669.9% from the stock's current price. View analysts' price targets for Synlogic.

News stories about SYBX stock have been trending very negative on Tuesday, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Synlogic earned a news impact score of -3.7 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news aboutSynlogic.

Some companies that are related to Synlogic include Evofem Biosciences (EVFM), Bicycle Therapeutics (BCYC), MannKind (MNKD), Galera Therapeutics (GRTX), Stemline Therapeutics (STML), Syros Pharmaceuticals (SYRS), Gemphire Therapeutics (GEMP), Geron (GERN), Aduro BioTech (ADRO), AMAG Pharmaceuticals (AMAG), Lexicon Pharmaceuticals (LXRX), Mallinckrodt (MNK), XOMA (XOMA), OptiNose (OPTN) and Selecta Biosciences (SELB).

Based on aggregate information from My MarketBeat watchlists, some companies that other Synlogic investors own include Reata Pharmaceuticals (RETA), Approach Resources (AREX), Precision Drilling (PDS), First Financial Bankshares (FFIN), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Corbus Pharmaceuticals (CRBP), Nektar Therapeutics (NKTR), Anavex Life Sciences (AVXL) and Progenics Pharmaceuticals (PGNX).

Synlogic trades on the NASDAQ under the ticker symbol "SYBX."

Shares of SYBX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SYBX stock can currently be purchased for approximately $1.84.

Synlogic has a market capitalization of $59.34 million and generates $2.22 million in revenue each year. The biotechnology company earns $-51,370,000.00 in net income (profit) each year or ($1.70) on an earnings per share basis. Synlogic employs 74 workers across the globe. View additional information about Synlogic.

The official website for Synlogic is http://www.synlogictx.com/.

Synlogic's mailing address is 301 Binney St. Suite 402, Cambridge MA, 02142. The biotechnology company can be reached via phone at 617-401-9975 or via email at [email protected]